← Leaderboards
Nelly Cecile Joseph-Mathurin
Washington University
$282,147
Attributed
$282,147
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $94K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$282,147 · 1
By mechanism
K01$282,147 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Rajat Dhar$2,619,062
- Tamara G Hershey$23,064,451
- Joseph P Culver$22,566,427
- Yin Cao$6,585,192
- Randall J Bateman$192,965,895
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposS DiseaseAge RelatedAbeta AccumulationAtrophicAmyloidAmyloid Beta-Protein PrecursorBlood-Brain Barrier DisruptionAssociated SymptomAstrocytesCerebral EdemaAutosomal Dominant Alzheimer&AposBiologicalBiological MarkersBlood - Brain Barrier AnatomyAmyloid Beta-ProteinBlood Brain Barrier DysfunctionBlood VesselsBrainCardiovascular DiseasesCareer DevelopmentCareer MobilityAbeta ClearanceCerebral Hemisphere Hemorrhage
Grant awards (3)
Evaluation of the neurovascular unit in the setting of pathogenesis and treatment of autosomal dominant Alzheimer disease$94,049
K01 · FY2025 · AG · contact PI
Evaluation of the neurovascular unit in the setting of pathogenesis and treatment of autosomal dominant Alzheimer disease$94,049
K01 · FY2024 · AG · contact PI
Evaluation of the neurovascular unit in the setting of pathogenesis and treatment of autosomal dominant Alzheimer disease$94,049
K01 · FY2023 · AG · contact PI